Literature DB >> 8929364

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials.

C H Hennekens1, C M Albert, S L Godfried, J M Gaziano, J E Buring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8929364     DOI： 10.1056/NEJM199611283352207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

Review 1.  Advances in the medical management of acute coronary syndromes.

Authors:  C P Cannon
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.

Authors:  A V Maksimenko; E G Tischenko
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

Review 3.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

4.  Acute Transmural Myocardial Infarction.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

5.  Linking joint commission inpatient core measures and national patient safety goals with evidence.

Authors:  Andrew L Masica; Kathleen M Richter; Paul Convery; Ziad Haydar
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-04

6.  Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.

Authors:  Spyridon Liosis; Timm Bauer; Rudolf Schiele; Helmut Gohlke; Martin Gottwik; Hugo Katus; Georg Sabin; Ralf Zahn; Steffen Schneider; Bernhard Rauch; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

7.  Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis.

Authors:  A Owen
Journal:  BMJ       Date:  1998-07-25

8.  The effects of health changes on projections of health service needs for the elderly population of the United States.

Authors:  B H Singer; K G Manton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

9.  AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.

Authors:  Quang T Nguyen; Federico Colombo; Robert Clement; Hugues Gosselin; Jean-Lucien Rouleau; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

10.  Change in mRNA Expression after Atenolol, a Beta-adrenergic Receptor Antagonist and Association with Pharmacological Response.

Authors:  Utkarsh Kohli; Britney L Grayson; Thomas M Aune; Laxmi V Ghimire; Daniel Kurnik; C Michael Stein
Journal:  Arch Drug Inf       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.